S3-Leitlinie Kolorektales Karzinom
Leitlinienprogramm Onkologie·2026
The S3 guideline on colorectal cancer (version 3.2, March 2026) provides evidence-based recommendations for prevention, screening, therapy, and follow-up in Germany. Key updates include new data on treatments such as Ipilimumab/Nivolumab and Encorafenib/Cetuximab, and the introduction of new chapters on pathology, supportive therapy, and rehabilitation.
View the guideline in the AWMF register→S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
Leitlinienprogramm Onkologie·2026
The guideline covers prevention, diagnosis, therapy, and follow-up of lung cancer, with updates including revisions of chapters on risk factors, smoking, and interventional procedures. It also updates the TNM classification, communication, and therapeutic spectrum in various chapters.
View the guideline in the AWMF register→Magenkarzinom - Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs
Leitlinienprogramm Onkologie·2025
The guideline covers the diagnosis and treatment of gastric adenocarcinomas and gastroesophageal junction adenocarcinomas, addressing various aspects from risk factors to palliative care. Key updates include a focus on preventive measures for CDH1- and CTNNA1-positive individuals and the establishment of FLOT as a perioperative chemotherapy concept.
View the guideline in the AWMF register→Supportive Therapie bei onkologischen PatientInnen
Leitlinienprogramm Onkologie·2025
The guideline "Supportive Therapy for Oncology Patients" Version 2.0, April 2025, provides evidence-based recommendations for improving the quality of life and managing side effects in cancer patients. Key updates include new chapters on central neurotoxicity and cardiotoxicity, as well as gender-sensitive language revisions.
View the guideline in the AWMF register→